Active Ingredient: Tildrakizumab
Tildrakizumab is indicated for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy.
For this indication, competent medicine agencies globally authorize below treatments:
Subcutaneous
100 - 100 mg
From 100 To 100 mg once every day
The recommended dose of tildrakizumab is 100 mg by subcutaneous injection at weeks 0 and 4 and every 12 weeks thereafter. In patients with certain characteristics (e.g. high disease burden, body weight ≥90 kg) 200 mg may provide greater efficacy.
Consideration should be given to discontinuing treatment in patients who have shown no response after 28 weeks of treatment. Some patients with initial partial response may subsequently improve with continued treatment beyond 28 weeks.
Tildrakizumab is administered by subcutaneous injection. Injection sites should be alternated. Tildrakizumab should not be injected into areas where the skin is affected by plaque psoriasis or is tender, bruised, red, hard, thick, or scaly.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
